Professor Lazar Velicki

Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia)

Follow

Contributor content

In silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy – SILICOFCM.

Presentation

In silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy – SILICOFCM.

ESC 365 is supported by

novartis

Explore sponsored resources